HHS Launches Pilot Program of Fast Molecular POC Test for COVID-19

U.S. Department of Health and Human Services Launches Pilot Program of Fast Molecular POC Test for COVID-19 | site |


HHS says Alaska, Florida, Louisiana, New Jersey, and Texas Receive First Shipments of Test Used in NBA Bubble


(Information contained in HHS press release: November 19, 2020) The U.S. Department of Health and Human Services (HHS) has launched a pilot program with five states to use portable, cartridge-based COVID-19 molecular test kits that provide rapid results. The pilot program will assess how to best integrate diagnostic technology developed by Cue Health, Inc., into strategies for disease surveillance and infection control in institutions such as nursing homes. Used successfully as the primary molecular point-of-care (POC) test to control the spread of COVID-19 within in the National Basketball Association “bubble,” as well as by leading healthcare providers in the U.S., the nasal swab POC test generates results in ab...

Trump Administration Makes Major Investment to Increase Availability of Fast Molecular POC Test | site |


Federal investment will scale up portable molecular test and acquire for national use


(October 13, 2020) - - Today, October 13, 2020, the U.S. Department of Health and Human Services published the following information: Today, the U.S. Department of Health and Human Services (HHS) in collaboration with the Department of Defense (DOD) awarded a $481 million Other Transaction Agreement to Cue Health, Inc. to expand U.S. production capacity for a cartridge-based point-of-care COVID-19 molecular test that produces results in about 20 minutes. This partnership with HHS and DOD will allow Cue to expand its industrial base and increase domestic production to 100,000 COVID-19 test kits per day by March 2021, and demonstrate this capacity through the delivery of six million COVID-19 tests and 30,000 instruments to the U.S. Government to support the...